k Early diagnosis of pancreatic cancer by urine test announced by Hirotsu Bio November 16, 2021, Tokyo, Japan Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening system to detect earlystage pancreatic cancer patients using their NNose system in Tokyo on Tuesday, November 16, 2021. NNose system uses odor sensor of nematodes for cancer patients urine, a specific nematode C.elegans shows attractive or repulsive responses for the urine of cancer and healthy persons. Photo by Yoshio TsunodaAFLO Editorial Stock Photo - Afloimages
Sign up
Login
All images
Early diagnosis of pancreatic cancer by urine test announced by Hirotsu Bio November 16, 2021, Tokyo, Japan   Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening system to detect early stage pancreatic cancer patients using their N Nose system in Tokyo on Tuesday, November 16, 2021. N Nose system uses odor sensor of nematodes for cancer patients  urine, a specific nematode  C.elegans  shows attractive or repulsive responses for the urine of cancer and healthy persons.          Photo by Yoshio Tsunoda AFLO
ED

Early diagnosis of pancreatic cancer by urine test announced by Hirotsu Bio

November 16, 2021, Tokyo, Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening system to detect early-stage pancreatic cancer patients using their N-Nose system in Tokyo on Tuesday, November 16, 2021. N-Nose system uses odor sensor of nematodes for cancer patients' urine, a specific nematode (C.elegans) shows attractive or repulsive responses for the urine of cancer and healthy persons. (Photo by Yoshio Tsunoda/AFLO)

Details

ID
174530639

Collection

License type
Editorial

Creation date
16-11-2021

Contact Aflo for all commercial uses.


Sign in
Member access
Login not found.